Do not use on an empty stomach
Lillys Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind phase 3b trial for adults with active psoriatic arthritis and obesity or overweight
Provider dashboards with escalation rules: Care teams need concise information instead of low-value alerts
Ongoing monitoring and clinical use continue to support its safety when prescribed appropriately and used under professional guidance
DENVER, May 15, 2025 /PRNewswire/ -- Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, today announced the launch of My Custom Weight Loss Kit , a new offering that helps members access curated care plans that may include prescription medications and wellness-focused supplements
Indiana Academy of Science, Indianapolis, IN